Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet

Eberhard-Karls-Universität Tübingen Universitätsklinikum

Curevac Ag

Andreas Hettich Gmbh & Co Kg

Eberhard-karls-universitat Tubingen

Eberhard Karls Universitat Tubingen Medizinische F Akultat

Acandis Gmbh

Aimecs Gmbh

Hans-Peter Wendel

Patrick Baumhof

Giorgio Cattaneo

Frank K Gehring

Lusine Danielyan

Timea Keller

Meltem Avci-adali

Stefan Sinn

Tobias Walker

Andrea Nolte

Torsten Kluba

Georg Siegel

Claus Claussen

Hinnak Northoff

Massimo Dominici

Rainer Kehlbach

Lothar Müller

Juergen Weindl

Hermann Schlüsener

Richard Schaefer

Bernd Neumann

Ruediger Bantleon

Andreas Von Ameln-Mayerhofer

The invention relates to a polyribonucleotide, a cosmetic and pharmaceutical compound that has the polyribonucleotide and a medicinal product that has the polyribonucleotide and the compound.

Stabilized polyribonucleotide coding for an elastic fibrous protein

The present invention relates to a nucleic acid molecule, a genetic construct, siRNA molecules and a composition which comprises the nucleic acid molecule and/or the genetic construct and/or the siRNA molecules and can be used for inhibition of the expression of endothelial adhesion molecules. The invention also relates to a device, which is coated with the aforementioned molecules, the composition or the construct, or contains them. The present invention further relates to a corresponding use of the nucleic acid molecule, of the genetic construct or of the siRNA molecules and a method of inhibition of the expression of adhesion molecules and a method of vessel grafting, lung transplantation, treatment of lung transplants, and a method of treatment of the open heart within the scope of cardioplegia.

siRNA molecules for the treatment of blood vessels

Growing community of inventors

Balingen, Germany

Hans-Peter Wendel